| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |